News
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the National Pharmacy Association.
Novo Nordisk A/S (NYSE:NVO) is among the. Novo Nordisk A/S (NYSE:NVO) lowered its operating profit growth projections to 10–16% (from 16-24%) and revenue growth projections to 8-14% (from 13-21%) at ...
Peter Kyle said he wants the likes of Wegovy and Mounjaro to be 'widely used' and made 'available to everyone from every ...
The weight loss injection, Wegovy, arrived in New Zealand - on prescription - with great fanfare only a couple of months ago.
Amy Schumer has undergone back surgery. The Life and Beth actress - who has six-year-old son Gene with husband Chris Fischer ...
FAT jabs could be made available over the counter at pharmacies without the need for a GP to get involved. It is one idea ...
If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...
Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...
10hon MSN
A study found jabs were linked to a 'modestly increased risk' of diabetic retinopathy-a condition caused by damage to blood ...
Novo Nordisk A/S is suffering from headwinds in its core anti-obesity medications market. Click here to find out why NVO ...
In Novo Nordisk’s legal fight against dozens of U.S. pharmacies and companies selling cheaper copies of its weight-loss drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results